RF SAFE

Media accountability · Public participation

Cover the Evidence. Publish the Comment Link.

The HHS wireless-radiation review deserves scrutiny—and the public deserves a way into the record.

RF Safe editorial · September 22, 2026 · Day-two archive snapshot

A public-health question deserves a public doorway

The federal government has invited Americans to help shape its investigation of radiofrequency and electromagnetic-field exposure. That invitation should be easy to find in the news. Readers should learn what evidence is being requested, which questions remain unresolved and exactly where to submit a response.

RF Safe welcomes the Trump administration and Secretary Robert F. Kennedy Jr. opening this process. Journalists should scrutinize their claims. They should apply the same scrutiny to reassuring claims, exposure standards and the institutions evaluating the evidence. A direct comment link is a public service, not an endorsement of a politician.

HHS is asking for research, exposure measurements, clinical observations and personal experiences, including information concerning vulnerable populations and cumulative exposure. This is an opportunity to improve the research agenda—not a vote that determines scientific truth. [2][3]

Scientific American: a case study in the missing next step

Scientific American’s September 22 article emphasizes reassuring findings and the weaknesses of much RF research. It discusses the HHS request and acknowledges research limitations. But it does not provide the HHS docket number, deadline or direct submission link. [1]

The article points readers toward WHO-commissioned reviews and the 2024 COSMOS cohort. It does not explain the National Toxicology Program’s positive animal findings or the WHO-commissioned animal review’s high-certainty tumor findings. It also does not identify the ICNIRP role of Ken Karipidis, whose research it discusses. [1]

Those are specific editorial choices worth challenging. This is a critique of one article, not a systematic audit of every newsroom. These omissions do not establish a coordinated campaign. Calling them a “psyop” would assert more than the evidence shows. The stronger demand is precise: give readers the participation details, consequential contrary findings and relevant institutional context.

The animal evidence belongs in the conversation

The National Toxicology Program reported clear evidence of malignant heart schwannomas in male rats and some evidence of malignant gliomas and adrenal-gland tumors. Findings in female rats and mice were less clear. NIEHS explicitly says the results challenge the assumption that RF exposure without significant heating is necessarily unconcerning. [4]

These were whole-body animal exposures, at levels and durations that cannot be translated directly into ordinary human phone use. They did not test today’s full range of wireless technologies. Those limitations matter; so does the positive finding. [4]

A WHO-commissioned animal-cancer systematic review rated evidence for increased glioma and heart schwannoma in male rats as high certainty. A 2026 corrigendum is linked with the original review below. These endpoint-specific findings do not establish human risk at compliant exposure levels, but they warrant explicit discussion when a review series is presented as reassurance. [5][6]

The public deserves the result and the reasoning used to interpret it. If an assessment concludes that animal findings should not change human exposure limits, explain the dose comparisons, uncertainties and assumptions. “Animal study” is a reason to examine translation carefully, not a reason to make the evidence disappear.

COSMOS is evidence—not an all-clear for every exposure

COSMOS followed 264,574 participants for a median of 7.12 years, observing 149 gliomas, 89 meningiomas and 29 acoustic neuromas. In the highest cumulative call-time group, the glioma hazard ratio was 1.07, with a 95% confidence interval of 0.62–1.86. That estimate did not establish an increase; its interval also leaves substantial uncertainty. [7]

The prospective design and exposure calibration are strengths. Follow-up duration is not total lifetime phone use: participants included people with long prior use. Still, rare outcomes and subgroup analyses limit precision. Call time is an imperfect measure of absorbed RF dose, and the authors acknowledge residual exposure misclassification. [8]

The useful conclusion is that this study found no association in its analyses. It cannot settle every tumor type, waveform, susceptible subgroup or lifetime exposure scenario. [7][8]

That distinction should guide both advocacy and journalism. A study need not be worthless to have important limits. A reassuring estimate need not be fabricated to be overextended in public messaging. Ask which risks a study can meaningfully constrain—and which questions it was not designed to answer.

Disclose the standards-setting connections

Ken Karipidis is ICNIRP’s vice chair. His institutional biography records Main Commission membership beginning in 2020 and the vice-chair role beginning in July 2024. It also describes his ARPANSA responsibilities and participation in Australian standards work. Those roles are relevant context when his evidence reviews inform discussion of exposure limits. [9]

Maria Feychting, first author of COSMOS, is a former ICNIRP vice chair. The paper discloses her past Commission membership; ICNIRP’s own membership announcement records her leadership role. The connection is documented, not secret. [8][10]

Expertise can legitimately lead someone to serve on a standards body and conduct research in the same field. That overlap does not prove a study is wrong, an author is corrupt or a financial conflict exists. It does create a reasonable governance question: how much independent reassessment occurs when evidence reviews concern standards developed by overlapping expert networks?

  • Disclose current and former standards roles, funding and relevant commercial interests.
  • Publish review protocols, extraction tables and reasons for certainty ratings.
  • Invite independent teams to test consequential methodological decisions.
  • Explain how disagreements affect the final assessment instead of presenting institutional agreement as the evidence itself.

The same disclosure standard applies to advocates. RF Safe founder John Coates holds patents involving optical technology and advocates Li-Fi adoption. Readers should know that interest when evaluating RF Safe’s proposed alternatives.

What a stronger investigation would ask

RF Safe’s concern is that a framework dominated by protection against established acute heating effects may not adequately resolve questions about chronic exposure, susceptibility and biological signaling. Calling RF radiation non-ionizing answers a question about photon energy; it does not, by itself, answer every question about biological interaction. Equally, observing a biological change does not automatically establish an adverse health effect.

Our “biological fidelity” framework proposes investigating whether defined exposures can disturb signal timing, regulation or recovery under particular physiological conditions. It is a research hypothesis. Testing it requires measured exposures, suitable controls, reproducible endpoints and a demonstrated connection between a signal change and impaired function.

A useful federal research agenda would compare relevant waveforms and exposure durations, examine combined stressors and susceptible groups, and distinguish transient responses from lasting harm. Standards should be examined as they actually operate, including their averaging rules and additional restrictions—not caricatured as one temperature reading.

The 2021 D.C. Circuit remand gives this demand a concrete regulatory context. The court required a reasoned explanation for the FCC’s treatment of evidence, including non-cancer effects and concerns about children and long-term exposure. It did not vacate the limits or determine that all compliant RF exposure is harmful. [12]

Public Law 90-602 also deserves attention. Its research responsibilities are reflected in 21 U.S.C. § 360ii, which directs an electronic-product radiation-control program. Ask HHS for a continuing, funded program with public milestones, independent replication and clear explanations of how findings inform policy. [13]

Day two: 502 archived comments, many questions still to represent

At the September 22, 5 p.m. update, RF Safe’s archive contained 502 comment records. AI-assisted review covered 490 comment bodies; 12 records remained dependent on attachment review. The archive also listed 49 submission attachments not yet reviewed. This is a dated archive snapshot, not a verified live government total. [15]

  • 260 neurological concerns; 197 research requests; 183 children’s issues.
  • 170 infrastructure concerns; 137 Wi-Fi; 97 access and accommodation.
  • 78 electromagnetic-sensitivity reports; 70 cancer; 65 optical alternatives.
  • 31 reproductive concerns; 22 mechanisms; 1 Section 704.

These are overlapping topic tags, not verified diagnoses or independent counts of affected people. One submission can appear in several categories. AI classification and incomplete attachment review can miss themes. The numbers describe this record; they do not measure disease prevalence, prove exposure caused symptoms or demonstrate media suppression.

RF Safe particularly wants more substantive discussion of Section 704’s restriction on certain state and local wireless-facility decisions based on RF environmental effects when facilities meet FCC rules. That restriction does not prohibit citizens from commenting. Changing the statute requires Congress. Explain the practical consequences and the remedy you seek. [14]

Explore the comments and their connections →

Make participation the next step

There is no need to manufacture certainty to write a useful comment. Describe what happened, distinguish observations from suspected causes, attach the strongest evidence you have and make a specific request. Clinicians can describe patterns; researchers can identify methodological gaps; engineers can submit measurements; families can explain their experiences and the questions they need answered.

HHS · research and health

Submit by October 21, 2026

Docket HHS-OASH-2026-0397. Include research priorities, exposure data, clinical observations and experiences. Review what personal information you include: submissions may become public.

File with HHS ↗

RF Safe’s evidence and comment guide →

FCC · exposure-rule record

File separately in ET 13-84

Address the remand, exposure assumptions and evidence the FCC should evaluate. DA 26-997 sets a deadline 30 days after Federal Register publication; verify the applicable filing date. The HHS deadline is not automatically the FCC deadline. [11]

File with the FCC ↗

Use RF Safe’s FCC comment helper →

What every newsroom can publish now

  • The official notice, docket, deadline and direct submission link.
  • The questions the government is asking and the kinds of evidence it accepts.
  • The strongest relevant findings, their limitations and disagreements about interpretation.
  • Relevant institutional affiliations and how review independence is protected.
  • A follow-up explaining what agencies do with the public record.

RF Safe also advocates practical exposure-reduction choices, including wired connections and optical wireless compatibility. The Li-Fi compatibility campaign and Clean Aether Act model proposal offer policy ideas for readers to examine; they are proposals, not enacted requirements.

Question the claims. Examine the standards. Give the public the link. A transparent investigation needs rigorous scrutiny and an accessible public record. Americans deserve both.

Sources and official records

Primary research, official records and documented affiliations support the factual claims. Policy recommendations and the biological-fidelity framework are RF Safe’s positions.

  1. Scientific American: RFK Jr., electromagnetic fields and exposure, September 22, 2026
  2. HHS: public input on electromagnetic fields and wireless radiation
  3. Federal Register: HHS notice and October 21 deadline
  4. NIEHS: cell phones and the National Toxicology Program findings
  5. Mevissen et al.: WHO-commissioned animal cancer review, 2025
  6. 2026 corrigendum to the animal cancer review
  7. Feychting et al.: COSMOS prospective cohort study, 2024
  8. COSMOS full article, methods and competing-interest disclosures
  9. ICNIRP: Ken Karipidis, vice chair
  10. ICNIRP: membership transition and former vice chair Maria Feychting
  11. FCC Public Notice DA 26-997: ET Docket 13-84
  12. 2021 D.C. Circuit opinion: Environmental Health Trust v. FCC
  13. 21 U.S.C. § 360ii: electronic product radiation control program
  14. 47 U.S.C. § 332: local wireless-facility siting restriction
  15. RF Safe archive: review coverage and supporting records